DR9.1 | Leprosy Epidemiology Classification and Clinical Features — Summary & Reflection

KEY TAKEAWAYS

Leprosy is a chronic infection by Mycobacterium leprae, an uncultivable acid-fast bacillus with tropism for skin and peripheral nerves; its clinical form is determined by the host's cell-mediated immunity. Diagnosis is clinical and rests on three WHO cardinal signs — any ONE suffices: a hypopigmented/reddish anaesthetic patch, a thickened peripheral nerve, or a positive slit-skin smear. Two SEPARATE classification systems must be kept distinct. The Ridley-Jopling spectrum is immunological/histological and runs TT → BT → BB → BL → LL (with Indeterminate as an early, off-spectrum lesion), from the high-immunity paucibacillary tuberculoid pole to the low-immunity multibacillary lepromatous pole. The WHO operational classification is a practical, treatment-deciding dichotomy: paucibacillary (PB) = ≤5 skin lesions AND a negative smear, treated with rifampicin + dapsone for 6 months; multibacillary (MB) = >5 lesions OR a positive smear, treated with rifampicin + dapsone + clofazimine for 12 months — a positive smear always means MB. Epidemiologically, India reports the most new cases worldwide, and the NLEP pursues elimination (< 1 case per 10,000 population) with free MDT, active surveillance, and contact prophylaxis. Correct, early classification is the foundation for everything that follows in leprosy care.

REFLECT

Think about the farmer in the opening scenario — eight months of an anaesthetic patch treated as a fungal infection because nobody tested its sensation. Reflect on why leprosy is so often missed at first contact, and what one change in your own routine examination of any hypopigmented skin lesion would prevent that delay. Now consider the two classification systems you have learned: when you next see a confirmed case, how will you deliberately keep the Ridley-Jopling assessment (which tells you about immunity, prognosis, and reaction risk) separate from the WHO operational assignment (which tells you the drug regimen and duration)? Holding both frameworks at once, without confusing them, is the clinical discipline that distinguishes a confident leprosy diagnostician from a hesitant one — and it is a discipline you build deliberately, case by case.